Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Antimicrobial Chemotherapy|October 13, 2022
Rapid cefiderocol NP test for detection of cefiderocol susceptibility/resistance in EnterobacteralesPatrice Nordmann, Maxime Bouvier, Laurent Poirel, et al.
Antibiotics (Basel, Switzerland)|November 11, 2022
Genomic Characterization of an Extensively Drug-Resistant Extra-Intestinal Pathogenic (ExPEC) <i>Escherichia coli</i> Clinical Isolate Co-Producing Two Carbapenemases and a 16S rRNA MethylaseMustafa Sadek, Alaaeldin Mohamed Saad, Patrice Nordmann, et al.
The Journal of Antimicrobial Chemotherapy|March 15, 2023
In vitro activity of cefepime/zidebactam and cefepime/taniborbactam against aztreonam/avibactam-resistant NDM-like-producing Escherichia coli clinical isolatesChristophe Le Terrier, Patrice Nordmann, Mustafa Sadek, et al.
Antimicrobial Agents and Chemotherapy|April 11, 2023
Impact of Minor Carbapenemases on Susceptibility to Novel β-Lactam/β-Lactamase Inhibitor Combinations and Cefiderocol in <i>Enterobacterales</i>Mustafa Sadek, Juan Bosch Duran, Laurent Poirel, et al.
Diagnostic Microbiology and Infectious Disease|September 16, 2022
Evaluation of novel immunological rapid test (K.N.I.V.O. Detection K-Set) for rapid detection of carbapenemase producers in multidrug-resistant gram negativesMustafa Sadek, Maxime Bouvier, Auriane Kerbol, et al.
JIMD Reports|May 13, 2024
Normal transferrin glycosylation does not rule out severe ALG1 deficiencyInez Bosnyak, Mustafa Sadek, Wasantha Ranatunga, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|June 30, 2020
Genetic Characterization of Carbapenemase-Producing <i>Enterobacter cloacae</i> Complex and <i>Pseudomonas aeruginosa</i> of Food of Animal Origin from EgyptMustafa Sadek, Ahmed M Soliman, Hirofumi Nariya, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 6, 2024
Reduced susceptibility to aztreonam-avibactam conferred by acquired AmpC-type β-lactamases in PBP3-modified Escherichia coliNicolas Helsens, Mustafa Sadek, Christophe Le Terrier, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 27, 2025
Combined resistance mechanisms leading to high-level of cefiderocol resistance among NDM-like producing E. coli ST167 clinical isolatesMustafa Sadek, Juan Bosch Duran, Trinad Chakraborty, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2024
Relative inhibitory activities of newly developed diazabicyclooctanes, boronic acid derivatives, and penicillin-based sulfone β-lactamase inhibitors against broad-spectrum AmpC β-lactamasesChristophe Le Terrier, Patrik Mlynarcik, Mustafa Sadek, et al.
Pageof 5